These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 31640932)
1. Optimization of the benzamide fragment targeting the S Deng X; Wang N; Meng L; Zhou S; Huang J; Xing J; He L; Jiang W; Li Q Bioorg Chem; 2020 Jan; 94():103366. PubMed ID: 31640932 [TBL] [Abstract][Full Text] [Related]
2. Rapid generation of novel benzoic acid-based xanthine derivatives as highly potent, selective and long acting DPP-4 inhibitors: Scaffold-hopping and prodrug study. Li Q; Meng L; Zhou S; Deng X; Wang N; Ji Y; Peng Y; Xing J; Yao G Eur J Med Chem; 2019 Oct; 180():509-523. PubMed ID: 31336309 [TBL] [Abstract][Full Text] [Related]
3. Identification and structure-activity relationship exploration of uracil-based benzoic acid and ester derivatives as novel dipeptidyl Peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. Li Q; Deng X; Jiang N; Meng L; Xing J; Jiang W; Xu Y Eur J Med Chem; 2021 Dec; 225():113765. PubMed ID: 34399391 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors. Li Q; Han L; Zhang B; Zhou J; Zhang H Org Biomol Chem; 2016 Oct; 14(40):9598-9611. PubMed ID: 27714283 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel uracil derivatives incorporating benzoic acid moieties as highly potent Dipeptidyl Peptidase-IV inhibitors. Huang J; Deng X; Zhou S; Wang N; Qin Y; Meng L; Li G; Xiong Y; Fan Y; Guo L; Lan D; Xing J; Jiang W; Li Q Bioorg Med Chem; 2019 Feb; 27(4):644-654. PubMed ID: 30642693 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors. Li N; Wang LJ; Jiang B; Guo SJ; Li XQ; Chen XC; Luo J; Li C; Wang Y; Shi DY Bioorg Med Chem Lett; 2018 Jul; 28(12):2131-2135. PubMed ID: 29773502 [TBL] [Abstract][Full Text] [Related]
8. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors. Deng X; Han L; Zhou J; Zhang H; Li Q Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors. Sharma M; Gupta M; Singh D; Kumar M; Kaur P Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors. Li Q; Zhou M; Han L; Cao Q; Wang X; Zhao L; Zhou J; Zhang H Chem Biol Drug Des; 2015 Oct; 86(4):849-56. PubMed ID: 25787859 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators. Fang Y; Zhang S; Wu W; Liu Y; Yang J; Li Y; Li M; Dong H; Jin Y; Liu R; Yang Z Bioorg Chem; 2020 Jan; 94():103390. PubMed ID: 31662212 [TBL] [Abstract][Full Text] [Related]
12. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors. Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564 [TBL] [Abstract][Full Text] [Related]
13. The optimization of xanthine derivatives leading to HBK001 hydrochloride as a potent dual ligand targeting DPP-IV and GPR119. Li G; Meng B; Yuan B; Huan Y; Zhou T; Jiang Q; Lei L; Sheng L; Wang W; Gong N; Lu Y; Ma C; Li Y; Shen Z; Huang H Eur J Med Chem; 2020 Feb; 188():112017. PubMed ID: 31926470 [TBL] [Abstract][Full Text] [Related]
14. Surrogating and redirection of pyrazolo[1,5-a]pyrimidin-7(4H)-one core, a novel class of potent and selective DPP-4 inhibitors. Deng X; Shen J; Zhu H; Xiao J; Sun R; Xie F; Lam C; Wang J; Qiao Y; Tavallaie MS; Hu Y; Du Y; Li J; Fu L; Jiang F Bioorg Med Chem; 2018 Feb; 26(4):903-912. PubMed ID: 29373269 [TBL] [Abstract][Full Text] [Related]
15. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation. Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors. Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053 [TBL] [Abstract][Full Text] [Related]
17. Design and Discovery of Novel 1,3,5-Triazines as Dipeptidyl Peptidase-4 Inhibitor against Diabetes. Wang Y; Tang X; Yi L Pharmacology; 2019; 103(5-6):273-281. PubMed ID: 30799431 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, evaluation and molecular docking of prolyl-fluoropyrrolidine derivatives as dipeptidyl peptidase IV inhibitors. Sharma M; Gupta M; Singh D; Kumar M; Kaur P Chem Biol Drug Des; 2013 Aug; 82(2):156-66. PubMed ID: 23581745 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of azobicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes. Cho TP; Long YF; Gang LZ; Yang W; Jun LH; Yuan SG; Hong FJ; Lin W; Liang GD; Lei Z; Jing LJ; Shen GA; Hong SG; Dan W; Ying F; Ke YP; Ying L; Jun F; Tai MX Bioorg Med Chem Lett; 2010 Jun; 20(12):3565-8. PubMed ID: 20488702 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. Ji X; Su M; Wang J; Deng G; Deng S; Li Z; Tang C; Li J; Li J; Zhao L; Jiang H; Liu H Eur J Med Chem; 2014 Mar; 75():111-22. PubMed ID: 24531224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]